Breakthrough status for AZ’ lung cancer drug Imfinzi

31st July 2017 Uncategorised 0

US regulators have granted AstraZeneca’s Imfinzi breakthrough status for the treatment of certain patients with locally-advanced, unresectable non-small cell lung cancer (NSCLC).

More: Breakthrough status for AZ’ lung cancer drug Imfinzi
Source: News